Feedback / Questions
Posiphen (buntanetap) - Annovis Bio
https://www.businesswire.com/news/home/20231030501881/en/Annovis-Bio-Receives-Positive-Recommendation-to-Continue-Phase-23-Trial-of-Buntanetap-for-Alzheimer%E2%80%99s-Disease-Patients-From-the-Independent-Data-and-Safety-Monitoring-Board-DSMB
Oct 30, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next